<DOC>
	<DOCNO>NCT01942720</DOCNO>
	<brief_summary>This study design evaluate performance VCE assessment mucosal inflammation 6 month first VCE procedure</brief_summary>
	<brief_title>Monitoring Disease Activity Using Video Capsule Endoscopy ( VCE ) Crohn 's Disease ( CD ) Subjects</brief_title>
	<detailed_description>This prospective , multi-center ( 15 site ) study aim assess ability VCE ( Video capsule endoscopy ) detect change severity small bowel mucosal disease activity CD subject 6 month . Up 75 subject participate study . An interim analysis do study completion 20 subject . All subject enrol study pediatric and\or adult subject know Crohn 's disease</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>1 . Subject age 275 year , inclusive 2 . Subjects diagnosis know Crohn disease 3 . Referred ileocolonoscopy ( 4 week CE procedure ) 4 . Proven patency Agile capsule another approach deem clinically acceptable investigator , e.g . CT enterography , MRE , perform within 90 day prior enrollment . 5 . Subject parent agree sign consent form The presence follow exclude subject study enrollment : 1 . Subjects change IBD drug therapy baseline ileocolonoscopy VCE 2 . Subjects history prior ileocecectomy , Ileal PouchAnal Anastomosis ( IPAA ) J pouch ostomy 3 . Stricture see radiological exam . 4 . Indeterminate Colitis 5 . Ulcerative Colitis 6 . Antibiotic Associated Colitis 7 . Known history intestinal obstruction current obstructive symptom , severe abdominal pain accompany nausea vomiting , base investigator judgment . 8 . Nonsteroidal antiinflammatory drug include aspirin ( twice weekly ) , include aspirin 81mg daily , 4 week precede enrollment 9 . Suspected GI stricture , follow PillCamÂ® Patency study image study could prove patency GI tract . 10 . Subject expect undergo MRI examination within 7 day ingestion capsule . 11 . Subjects know suspected delayed gastric empty 12 . Subjects know suspected delay Small bowel motility 13 . Subject allergy know contraindication medication use study . 14 . Women either pregnant nursing time screening , childbearing potential agree practice medically acceptable method contraception . 15 . Unwillingness use medically accept method contraception throughout duration study 16 . Concurrent participation another clinical trial use investigational drug device . 17 . Subject cardiac pacemaker implant electromedical device 18 . Subject suffers life threaten condition . 19 . Subject history clinical evidence renal disease and/or previous clinically significant laboratory abnormality renal function parameter . 20 . Subject suffers condition , swallow problem , precludes compliance study and/or device instruction .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>